Sign In
Buy ARCT
$7.60
-0.0500 (-0.654%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: Immunic To Develop COVID Treatment, Gilead Strikes IO Partnership
11:51am, Wednesday, 22'nd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) * Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) * Ar
The Daily Biotech Pulse: Immunic To Develop COVID Treatment, Gilead Strikes IO Partnership
12:00am, Wednesday, 22'nd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs April 21)
Alnylam Pharmaceuticals,...
Arcturus Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
12:00pm, Tuesday, 21'st Apr 2020
Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeut
Bio Roundup: Alnylam's Billions, COVID-19 Vaccines, Moma Debuts & More
01:28pm, Friday, 17'th Apr 2020
The public markets are moving erratically, but Alnylam Pharmaceuticals showed this week that selling equity isn't the only way for biotech companies to
Arcturus Therapeutics Announces Pricing of $70.0 Million Public Offering of Common Stock
01:10pm, Thursday, 16'th Apr 2020
Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeut
The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant
12:09pm, Thursday, 16'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 15.) * Bio-Rad Laboratories, Inc. Class B Common Stock
Arcturus Therapeutics Announces Proposed Public Offering of Common Stock
08:01pm, Wednesday, 15'th Apr 2020
Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare di
3 Frontrunners In COVID-19 Vaccine Development: What You Need To Know
07:45pm, Wednesday, 15'th Apr 2020
As companies race against time to bring to market a vaccine for the new coronavirus — SARS-CoV-2 — that causes COVID-19, three contenders have emerged as ...
Clinical Plan Includes Healthy Volunteers in New Zealand and OTC-Deficient Patients Across Several Sites in United States Investor Conference Call at 4:00 pm ET Today SAN.
Stocks To Watch: Big Banks And Vaccine Players In The Spotlight
12:35pm, Saturday, 11'th Apr 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Pfizer, BioNTech, Arcturus Share Timelines For Human Testing As COVID-19 Vaccine Development Intensifies
05:43pm, Thursday, 09'th Apr 2020
The enormity of the coronavirus pandemic has forced biopharma companies to step up efforts to expeditiously develop vaccines and treatments for COVID-19. The Frontrunners Moderna Inc (NASDAQ: MRNA),
Biohaven on go with study of vazegepant in COVID-19 as others take action amid the pandemic
12:04pm, Thursday, 09'th Apr 2020
The FDA has signed off on a Phase 2 clinical trial evaluating intranasal administration of Biohaven Pharmaceutical Holding Company's (NYSE:BHVN) migraine med vazegepant, a calcitonin gene-related pept
Arcturus Therapeutics Announces Clinical Trial Timeline for its COVID-19 Vaccine
11:00am, Thursday, 09'th Apr 2020
GMP-Manufactured Batch to be Delivered in June 2020 Human Dosing Expected to Begin in Summer 2020 SAN DIEGO, April 09, 2020 -- Arcturus Therapeutics (the “Company”, NASDAQ:.
When Will a Coronavirus Vaccine be Ready? These 9 Programs Are Making Progress.
05:02pm, Monday, 30'th Mar 2020
A true return to normalcy is unlikely without a widely-available coronavirus vaccine. There are currently at least 47 Covid-19 vaccine programs under way. Here are some to keep an eye on.
The race to develop a COVID-19 vaccine
07:24pm, Sunday, 22'nd Mar 2020
The race for a coronavirus (COVID-19) vaccine is on in the ugliest of ways. Since December, scientists around the world have been racing to create the first vaccine against COVID-19, with vaccine tria
